 ATLANTA, May 17, 2021 GLOBE NEWSWIRE -- Alimera Sciences, Inc. NASDAQ: ALIM Alimera, a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, has announced the expansion of its leadership team with the appointment of David Dyer, M.D. as chief retina specialist, effective today. Dr. Dyer brings his extensive medical knowledge and business expertise to the company, while continuing to see patients out of his longstanding practice in Kansas City, Missouri. 